4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-24-000178
President of R&D acquired 637,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. President of R&D | 2024-01-09 | Grant or award | +637,500 | $1.93 | $1,230,375 | 6,615,348 | D |
| Derivatives | |||||||
| Schuetz Thomas J. President of R&D | 2024-01-09 | Grant or award · Stock Option (Right to Buy) | +637,500 | 637,500 | D | ||
Loading xslF345X05/ownership.xml…